Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.19.3
Subsequent Events (Details) - Subsequent Event
$ in Millions
Nov. 01, 2019
USD ($)
Pediatric Portfolio  
Subsequent Event [Line Items]  
Consideration $ 17.0
Proceeds from sale of assets 4.5
Assumption of debt on sale of assets 15.0
Pediatric Portfolio | AYTU BioScience, Inc  
Subsequent Event [Line Items]  
Convertible preferred stock received 12.5
Liabilities assumed by buyer 11.0
Payment Guarantee | Deerfield CSF  
Subsequent Event [Line Items]  
Guarantor obligation $ 25.7